Johnson & Johnson’s Legal Challenge Tests the Constitutionality of the False Claims Act
In a significant legal development, Johnson & Johnson is challenging the constitutionality of the False Claims Act (FCA) following a $1.6 billion judgment related to alleged fraudulent drug promotion practices. This action has provoked a robust legal debate, underscoring deep constitutional questions about the role of whistleblowers in pursuing fraud claims on behalf of the…